News

US FDA approves first cell-based gene therapy for rare genetic skin disorder
The U.S. Food and Drug Administration approved Abeona Therapeutics' gene therapy for a rare skin disorder on Tuesday. The gene therapy, called Zevaskyn, is approved to treat adult and pediatric ...
Novo Nordisk teams with telehealth firms Him, Ro to sell Wegovy at lower price
Hims and Hers Health Inc. soared in pre-market trading after Novo Nordisk A/S said it would sell its popular weight-loss drug ...
Stocktwits on MSN24m
Hims & Hers, LifeMD Stocks Surge On Novo Nordisk's Plan To Sell Wegovy Via Telehealth Operators
Novo Nordisk (NVO) on Tuesday announced that it is enabling select telehealth providers to offer Wegovy, expanding access to ...
Woman shares why she stopped using weight loss drug, Mounjaro, even after it helped her lose 31 kilos
Mounjaro, initially for type 2 diabetes, gains popularity for weight loss, yet users report severe side effects. Ellie Marie, after losing nearly five ...